SummitTX Capital’s ASP Isotopes ASPI Stock Holding History

SummitTX Capital’s Portfolio ASPI Stock Details ASPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,128	Closed	-$75.6K	–	763
2025 Q4	$75.6K	Buy	+14,128	New	+$112K	﹤0.01%	666

Other funds holding ASPI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RIM

Rovida Investment Management Grand Cayman, Cayman Islands $1.47B AUM 142.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

SummitTX Capital's ASPI Position: Q1 2026 in Review

SummitTX Capital sold out of ASP Isotopes (ASPI) in Q1 2026, closing a stake of 14,128 shares — an estimated $75.6K sold.

SummitTX Capital first reported a position in ASPI in Q4 2025 and held it in 1 quarter. The position peaked at $75.6K in Q4 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

SummitTX Capital reported no remaining ASP Isotopes position as of Q1 2026 after selling out during the quarter.
SummitTX Capital sold 14,128 ASP Isotopes shares in Q1 2026, an estimated $75.6K.
SummitTX Capital first reported a position in ASP Isotopes in Q4 2025 and held it in 1 quarter.
SummitTX Capital's ASP Isotopes position peaked at $75.6K in Q4 2025.
177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.